Arkolith/Insider Trading/RAPP/Form 4

Bredt David

Chief Scientific OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Jan 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$197K
Net Open-Market Flow
-$197K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Sell(S)7K$30.05$197K404K
Dec 31, 2025Grant(A)18K——411K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-002470) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML